BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5061528)

  • 1. [A new type of topical corticoid. Principle and experimental activity control].
    Escande JP
    Nouv Presse Med; 1972 Jan; 1(3):181-2. PubMed ID: 5061528
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of topical metal binding substances, vehicles, and corticosteroid creams on the allergic patch test reaction in metal-sensitive patients.
    Fischer T; Rystedt I
    Dermatol Clin; 1990 Jan; 8(1):27-31. PubMed ID: 2302861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dermatological externals, particularly their releasing capacity].
    Hagerman G
    Z Haut Geschlechtskr; 1973 Feb; 48(3):97-105. PubMed ID: 4266852
    [No Abstract]   [Full Text] [Related]  

  • 4. A guide to topical corticosteroids.
    Goldman L
    Am Fam Physician; 1973 Sep; 8(3):167-70. PubMed ID: 4729714
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of vehicle composition on the liberation and percutaneous penetration of corticosteroids].
    Moës-Henschel V; Jaminet F
    J Pharm Belg; 1975; 30(4):390-404. PubMed ID: 1206464
    [No Abstract]   [Full Text] [Related]  

  • 6. [The administration of corticosteroid ointments and creams].
    Polano MK
    Ned Tijdschr Geneeskd; 1986 Apr; 130(14):624-7. PubMed ID: 3703033
    [No Abstract]   [Full Text] [Related]  

  • 7. The activity of fluocinonide on diseases and healthy skin in comparison with other topical corticosteroids.
    Kalkoff KW
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):51-6. PubMed ID: 5291633
    [No Abstract]   [Full Text] [Related]  

  • 8. [Possibilities in the objective evaluation of effectiveness of corticoid preparations for external use].
    Lejhanec G; Hybásek P; Serák L; Smolan S; Viktorinová M
    Cesk Dermatol; 1974 Jan; 49(1):3-8. PubMed ID: 4814261
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dermatologic topical treatment. 2. Penetration of drugs. Views on vehicles and skin protection creams].
    Wahlberg JE
    Lakartidningen; 1971 Oct; 68():Suppl 4:75-80. PubMed ID: 5153825
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of a new corticosteroid, fluocinonide, in a scientifically designed base.
    Burdick KH
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):24-31. PubMed ID: 5291631
    [No Abstract]   [Full Text] [Related]  

  • 11. [New data on the use of dimethylsulfoxide in experimental and clinical dermatology (a survey of the literature)].
    Datskovskii BM; Zaks AS; Mitriukovskii LS
    Vestn Dermatol Venerol; 1973 Jan; 47(1):30-6. PubMed ID: 4575609
    [No Abstract]   [Full Text] [Related]  

  • 12. Design of the optimal topical system for fluocinonide.
    Reinstein J; Ostrenga J; Haleblian J; Shastri S; Poulsen B; Katz M
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):Suppl 67:13-8. PubMed ID: 5291642
    [No Abstract]   [Full Text] [Related]  

  • 13. [Approach to the technologic and biopharmaceutic evaluation of dermatological preparations].
    Curcio L; Rigamonti S
    Boll Chim Farm; 1971 Aug; 110(8):421-7. PubMed ID: 5137980
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel foam vehicle for delivery of topical corticosteroids.
    Huang X; Tanojo H; Lenn J; Deng CH; Krochmal L
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S26-38. PubMed ID: 15968261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basic viewpoints in the modern treatment of eczema].
    Schneider W
    Hautarzt; 1975 Feb; 26(2):88-91. PubMed ID: 236267
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacodynamic and metabolic characteristics of a new dermosteroid: Formocortal].
    Sala G; Castegnaro E
    G Ital Dermatol Minerva Dermatol; 1970 Jul; 45(7):451-62. PubMed ID: 5537424
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical corticoid therapy: a round table discussion. Part V. The base as a vehicle.
    Cutis; 1980 Apr; 25(4):441-3. PubMed ID: 7363671
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors influencing the formulation of semisolid preparations with special reference to corticosteroid products.
    Worthington HE
    Acta Derm Venereol Suppl (Stockh); 1973; 53():29-34. PubMed ID: 4518660
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biological properties of acetomepregenol ointment on the hydrophilic base CACAP].
    Alchangian LV; Maiatskaia TV; Alekseev KV; Li VN; Aĭvazian AA
    Vestn Dermatol Venerol; 1984 Dec; (12):52-5. PubMed ID: 6549421
    [No Abstract]   [Full Text] [Related]  

  • 20. [Penetration kinetics of topical steroids].
    Tronnier H
    Arch Klin Exp Dermatol; 1970; 237(3):769-73. PubMed ID: 5523569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.